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Abstract 10 
Hip resurfacing with cobalt-chromium (CoCr) alloy was developed as a surgical alternative to 11 
total hip replacement. However, the biological effects of nanoparticles generated by wear at 12 
the metal-on-metal articulating surfaces has limited the success of such implants. The aim of 13 
this study was to investigate the effects of the combined exposure to CoCr nanoparticles and 14 
cobalt ions released from a resurfacing implant on monocytes (U937 cells) and whether these 15 
resulted in morphology changes, proliferation alterations, toxicity and cytokine release. The 16 
interaction between prior exposure to Co ions and the cellular response to nanoparticulate 17 
debris was determined to simulate the situation in patients with metal-on-metal implants 18 
receiving a second implant. Effects on U937 cells were mainly seen after 120h of treatment. 19 
Prior exposure to Co ions increased the toxic effects induced by the debris, and by Co ions 20 
themselves, suggesting the potential for interaction in vivo. Increased TNF-Į VHFUHWLRn by 21 
resting cells exposed to nanoparticles could contribute to osteolysis processes in vivo, while 22 
increased IFN-Ȗ SURGXFWLRQ E\ DFWLYDWHG FHOOV FRXOG UHSUHVHQW FHOOXODU SURWHFWLRQ DJDLQVW23 
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tissue damage. Data suggest that interactions between Co ions and CoCr nanoparticles would 24 
occur in vivo, and could threaten the survival of a CoCr metal implant.  25 
 26 
Keywords: metal wear debris; hip replacements; nanoparticles; metal ions; cobalt-chrome 27 
alloy; monocytes 28 
 29 
1. Introduction 30 
The most common cause of failure of total hip arthroplasty is aseptic loosening of the implant 31 
initiated by adverse tissue response to prostheses wear particles (Luo et al., 2005). Current 32 
evidence indicates that the size of wear particles generated by CoCr alloy metal-on-metal 33 
(MoM) articulations is in the nanometre size range (Hosman et al., 2010). The large surface 34 
area enhances release of metal ions, predominantly Co and Cr ions, into the circulation 35 
(Lucarelli et al., 2004). Wear particles from articular surfaces are phagocytosed mainly by 36 
macrophages. When particles are phagocytosed in sufficient amounts, the macrophages enter 37 
an active state of metabolism, releasing an array of cytokines, chemokines, and growth 38 
factors inducing inflammation, which accelerates osteoclast formation and bone resorption 39 
resulting in periprosthetic osteolysis (Germain et al., 2003; Yagil-Kelmer et al., 2004). 40 
 41 
Circulating physiological levels of &RDQG&UDUHQRUPDOO\ȝJOȝ0(Andrews et 42 
al., 2011). Elevated levels of Co and Cr ions occur in both the hip synovial fluid and in 43 
peripheral blood after MoM hip replacement, and there is concern about the toxicity and 44 
biological effects of such ions both locally and systemically (Bisseling et al., 2011; 45 
Friesenbichler et al., 2012; Penny et al., 2013). 46 
 47 
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Co corrodes faster than Cr under physiological conditions (Xia et al., 2011) and, in contrast 48 
to Cr, Co ions tend to remain mobile, which is reflected in the higher levels measured in 49 
blood, allowing the ions to reach and enter remote organs (Afolaranmi et al., 2012). Elevated 50 
Co concentrations in patients with MoM implants are a concern, since increased Co levels in 51 
blood have also been reported to be associated with neurological (hand tremor, 52 
incoordination, cognitive decline, depression, vertigo, hearing loss, and visual changes) 53 
(Oldenburg et al., 2009; Tower, 2010), cardiac (myocardiopathy) (Dadda et al., 1994; 54 
Seghizzi et al., 1994; Gilbert et al., 2013) and endocrine (aberrant oestrogen signalling, 55 
altered the production or circulation of sex hormones, and altered thyroid metabolism) 56 
(Keegan et al., 2007; Oldenburg et al., 2009) symptoms.  57 
 58 
In addition to the above, data from the seventh annual report of the National Joint Registry 59 
for England and Wales showed high failure rates for MoM hip prostheses 60 
(http://www.njrcentre.org.uk/njrcentre/portals/0/njr%207th%20annual%20report%202010.pd61 
f), which led to the market recall of the DePuy ASRTM, both the Resurfacing and XL Systems 62 
in August 2010 (DePuy International Ltd, Leeds, UK) (MDA/2010/069). Following this, the 63 
Medicines and Healthcare products Regulatory Agency (MHRA) safety alert in September 64 
2010 drew attention to the long term biological safety of all types of MoM hip implants. In 65 
this document (MDA/2010/069; http://www.mhra.gov.uk/home/groups/dts-66 
bs/documents/medicaldevicealert/con093791.pdf) the MHRA explained the details behind the 67 
safety alert and included four situations in which measurements of blood metal ions in 68 
patients were recommended: 1) in patients who have symptoms associated with loose MoM 69 
bearings; 2) in patients showing radiological features associated with adverse outcomes 70 
including component position or small component size; 3) if the patient or surgeon are 71 
concerned regarding the MoM bearing; and 4) if there is concern about patients with higher 72 
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than expected rates of failure. The MHRA have suggested that combined whole blood Co and 73 
Cr levels of greater than 7ppb (7µg/l or 0.1µM of the combined ions) are associated with 74 
significant soft-tissue reactions and failed MoM hips. 75 
 76 
Aseptic loosening usually leads to revision surgery where the implant is removed and 77 
replaced with an alternative bearing (Maezawa et al., 2009; Naal et al., 2011; Sehatzadeh et 78 
al., 2012). At the time of revision these patients may have high circulating metal ion 79 
concentrations (particularly cobalt), and these may alter the response of the patient to the new 80 
device.   To investigate the effects of the metal ions already present in these patients in terms 81 
of the biological response to the new device, cells were pre-treated in vitro with 0.1µM Co in 82 
the present study for 4 days before being treated with the metal wear debris. Continued 83 
exposure to Co ion release from an existing implant may also influence the responses to wear 84 
debris and for this reason the combined effect of exposure to Co ions and wear debris was 85 
also investigated.   The concentration of Co ions used in the study was chosen to reflect the 86 
maximum circulating concentration recommended in patients with MoM implants by MHRA 87 
in 2010 (MDA/2010/069; http://www.mhra.gov.uk/home/groups/dts-88 
bs/documents/medicaldevicealert/con093791.pdf). 89 
 90 
U937 cells are a human macrophage-like cell line derived from human leukemic monocyte 91 
lymphoma (Yagil-Kelmer et al., 2004). This cell line has been used previously as the cell 92 
culture model to study the biological effects of different kinds of particles and ions, and it has 93 
been demonstrated that U937 cells have comparable responses to polyethylene particles 94 
(Matthews et al., 2001) and metal ions (Wang et al., 1996) as do primary macrophages in 95 
terms of cytokine release.  96 
 97 
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The aim of this study was to find out if exposure to CoCr nanoparticles released from a 98 
resurfacing implant could activate monocytes, and whether this resulted in cytotoxicity and 99 
cytokine release. The interactions between prior exposure to Co ions and the nanoparticulate 100 
debris, and between combined exposure to wear debris and Co ions, were determined in order 101 
to simulate the in vivo situation in patients with MoM implants. 102 
 103 
2. Methods 104 
2.1. Preparation of wear debris 105 
CoCr wear debris was a gift from DePuy International (Leeds, UK). A high-FDUERQ106 
content CoCr alloy (ISO 5832-12: Co Balance, Cr 26.0±30.0%, Mo 5.0±7.0%, Ni 1.0% max., 107 
Si 1.0% max., Mn 1.0% max., Fe 0.75% max., C 0.35% max., N 0.25% max.) hip resurfacing 108 
implant was worn on a multi-station hip joint simulator using the following protocol. The 109 
wear debris was produced over 250000 cycles using distilled water as the lubricating fluid.  110 
The use of only distilled water (instead of the more usual bovine serum (25% v/v) in distilled 111 
water) resulted in a more rapid and aggressive wear regime which produced a greater volume 112 
of wear debris of similar morphology and size for testing purposes to that produced under 113 
similar conditions in 25 per cent serum but in a more conducive time-frame (personal 114 
communication, Dr C. Hardaker, DePuy International, Leeds, UK).  Wear debris produced by 115 
hip simulator under different conditions has previously been shown to be of similar size and 116 
morphology (Brown et al., 2007).  117 
 118 
Once produced, the wear debris was centrifuged at 3500g for 20 minutes. The majority of the 119 
water was then aspirated. The remaining suspension was heat-treated (180°C for 5h, 60kPa) 120 
in a vacuum oven to eliminate the remaining water and destroy any endotoxin. The dry debris 121 
was then suspended in sterile phosphate buffered saline (PBS; Invitrogen; Paisley, UK). The 122 
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sterility of the treated wear debris was tested as described by Akbar et al. (2012) by exposing 123 
dendritic cells (isolated from bone marrow of male BALB/c (Harlan, UK) mouse femurs and 124 
tibias (Lutz et al., 1999)) to the debris for 24h, in vitro, and then assessing the expression of 125 
surface activation markers via flow cytometry. The debris was found not to increase the 126 
surface expression of CD40, CD86, or MHC II on these cells, and, therefore, the suspended 127 
debris was deemed sterile and endotoxin-free (data not shown). 128 
 129 
Heat treated wear debris was imaged with a Field Emission Scanning Electron Microscope 130 
(FE-SEM) (Hitachi SU-6600, Hitachi; Germany) at magnifications of 100-1000x. Energy 131 
Dispersive X-ray Spectroscopy (EDS) was used for quantitative analysis of elemental 132 
composition. Hitachi TM-1000 and EDSwift-TM software was used to obtain the images and 133 
chemical spectra of the wear debris. Metal ion release from the debris was determined by 134 
incubating ȝJGHEULVFP2 for 24h at 37oC in an atmosphere of 5% (v/v) CO2 in air in 135 
1ml of complete RPMI-1640 medium in the presence of 10% (v/v) foetal bovine serum (FBS) 136 
as described below.  The medium was collected and stored at -80oC until ICP-MS analysis 137 
using an Agilent 7700x octopole collision system in helium gas mode using scandium as 138 
internal standard.  Quantification was based on the maximum signal for a particular isotope, 139 
and five readings were taken, with the result taken as the mean value.  140 
 141 
2.2. Cell culture 142 
U937 (Human leukemic monocyte lymphoma cell line; European Collection of Cell Cultures) 143 
cells were cultured in RPMI-1640 medium supplemented with 10% (v/v) FBS, 50U/ml 144 
penicillin and 50µg/ml streptomycin. These cells were routinely split every three days at a 145 
ratio of 1:10 from a starting passage number of 4 and for no more than 20 passages. This was 146 
achieved by taking 3ml of cell suspension into a fresh 75cm2 culture flask containing 27ml of 147 
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fresh complete RPMI-1640 medium. Cells were activated by incubating them with 10nM 148 
phorbol 12-myristate 13-acetate (PMA, Sigma-Aldrich; Dorset, UK) for 72h (Lucarelli et al., 149 
2004). Activation was confirmed by monitoring cell morphology, adhesion, and aggregation 150 
on a Zeiss Imager.Z1 microscope using wet lenses (20X) every 24h. For cobalt pre-treatment 151 
of cells, Co2+ solutions were freshly prepared using cobalt chloride (CoCl2) (Alfa Aesar; 152 
Lancashire, UK) and diluted to 0.1µM in growth medium under sterile conditions. Resting 153 
and activated cells were incubated with 0.1µM Co2+ for 72h. 154 
 155 
2.3. Cell number and viability 156 
In order to assess cell viability, U937 cells were exposed to metal debris and Co2+ in resting 157 
and activated states for 24 and 120h. For both resting and activated U937 cells, the cells were 158 
cultured (1x104 cells/well) in 96-well plates with ȝJ debris/cm2 (5mg 159 
debris/1x106cells), 0.1µM of Co2+, or the combination of ȝJGHEULVFP2 plus 0.1µM of 160 
Co2+ in complete RPMI-1640 for 24 and 120h at 37°C under 5% (v/v) CO2. Culture medium 161 
was not changed during these incubation periods. At each culture endpoint, cells were 162 
washed twice with PBS to remove the debris layer before cell viability was assessed by the 163 
neutral red (NR) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 164 
assays, as described by Repetto et al. (2008) and Mosmann (1983), respectively. The cells 165 
were incubated with NR for 3h and MTT for 4h, and absorbance of the both NR and MTT 166 
assay samples were then measured at 540nm using a Bio-Rad Model 450 microplate reader 167 
(Bio-Rad, Hertfordshire, UK).  168 
 169 
Viability was also monitored microscopically by double staining with Acridine Orange (AO; 170 
Sigma-Aldrich; Dorset, UK) and Propidium Iodide (PI; Life Technologies; Paisley, UK) as 171 
previously described by Bank (1988). Cells were viewed using a Carl Zeiss Axio Imager 172 
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microscope under a 40X water immersion lens with a numeric aperture of 0.80. Fluorescence 173 
was excited using a mercury lamp and emission recorded using a fluorescein isothiocyanate 174 
(FITC)/Rhodamine filter block (485/515-530nm; 546/580-563nm) for AO and PI. Cells 175 
fluorescing green were scored as viable, and those fluorescing red as nonviable. 176 
 177 
2.4. Cell proliferation 178 
Resting and activated cells were cultured (1x104cells/well) in 96-well plates with ȝJ179 
debris/cm2, 0.1µM of Co2+, or the combination of ȝJGHEULVFP2 plus 0.1µM of Co2+ in 180 
complete RPMI-1640 for 24h at 37°C under 5% (v/v) CO2. U937 cell proliferation was then 181 
determined using a BrdU Cell Proliferation Immunoassay kit (kit number QIA58, Merck 182 
Chemicals; Nottingham, UK), as suggested by the manufacturer. Briefly, the BrdU label was 183 
diluted 1:2000 into fresh complete RPMI- PHGLXP 7R ODEHO WKH '1$ ȝO RI WKLV184 
working solution were added to cells in 96-well plates during the final 4 hours of the 185 
experiment. Plates were then centrifuged (300xg for 10min) and the supernatant aspirated. 186 
Cells were then fixed, permeabilized, and the DNA denatured. Plates were incubated for 187 
30min at room WHPSHUDWXUHDQGWKHIL[DWLYHGHQDWXULQJVROXWLRQZDVWKHQDVSLUDWHGȝORI188 
anti-BrdU antibody diluted in antibody dilution buffer were added to each well and incubated 189 
with the cells for 1h at room temperature. Cells were washed 3 times with 1X wash buffer, 190 
before ȝORISHUR[LGDVHJRDWDQWL-mouse IgG HRP conjugate diluted in conjugate diluent 191 
were incubated with the cells for 30min at room temperature. Plates were then flooded with 192 
dH2O, emptied, and incubated with ȝO RI VXEVWUDWH VROXWLRQ LQ WKH GDUN DW URRP193 
temperature for 15min. Following the addition of ȝORIVWRSVROXWLRQthe absorbance was 194 
measured using a Thermo Scientific Multiskan Ascent spectrophotometer plate reader at dual 195 
wavelengths of 450-540nm. 196 
 197 
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2.5. Cytokine production: ELISA 198 
Cytokine levels were determined by collecting the supernatants from the cell cultures at each 199 
end point. The concentrations of tumour necrosis factor-alpha (TNF-Į LQWHUIHURQ-Ȗ ,)1Ȗ) 200 
and interleukin-6 (IL-6) in the culture media were determined from aliquots of cell-free 201 
isolates using Ready-Set-Go! ELISA kits (eBioscience; Hatfield, UK) in accordance with the 202 
PDQXIDFWXUHU¶V LQVWUXFWLRQV (DFK RI WKH NLWV KDG D VHQVLWLYLW\ OHYHO RI pg/ml, and linear 203 
standard curves were generated between 0-SJPOIRU71)ĮDQG,)1ȖDQG-200pg/ml for 204 
IL-6.  The presence of metal ions in the medium did not influence the measurement of the 205 
cytokines. 206 
 207 
2.6. Statistics 208 
Statistical analyses were carried out by a one-way analysis of variance (ANOVA), followed 209 
E\D'XQQHWW¶VPXOWLSOHFRPSDULVRQWHVWDQGDWZR-sample t-test. Significance was assigned 210 
where p values were found to be <0.05. 211 
 212 
3. Results 213 
3.1. Characterisation of wear debris and release of metal ions 214 
Wear particles generated by the hip simulator process have been reported with a mean size of 215 
50nm (Brown et al, 2007).  SEM images show irregular shapes and sizes varying from the 216 
nano to the micro scale (from 150nm to 6.5µm). The larger irregular shaped particles suggest 217 
that the debris aggregates (Image 1), and this has been reported previously by Akbar and co-218 
workers (2012). Doorn et al (1998) isolated particles from MoM retrieval tissues that varied 219 
in size (51-116nm particles to micrometre sized aggregates) and shape. Moreover, metal 220 
particles (0.1-3 microns in size) have also been found in tissues post-mortem (Brown et al., 221 
2013). EDS analysis indicated that the wear debris is primarily composed of Co and Cr 222 
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(which is in agreement with the alloy composition (Singh and Dahotre, 2007)). Analysis of 223 
25 different particles indicated a mean composition of 59.57 per cent Co, 40.43 per cent Cr 224 
and a small amount of Mo which was below the limit of quantification. The CoCr wear debris 225 
released metal ions into culture medium as shown on Table 1.  Co was the predominant ion 226 
released after 24h incubation. The percentage dissolution of the debris over the 24h period 227 
was negligible, 0.000042%, although the cobalt concentration released was 1259.41+/- 39.58 228 
ng/ml. 229 
 230 
3.2. Cell viability 231 
In this study, the ȝJdebris/cm2 (5mg/1x106cells) concentration was chosen to mimic 232 
the local metallosis environment surrounding an implant. The viability of the cells was 233 
assessed after exposure to Co ions, to wear debris, and to a combination of the wear debris 234 
and Co ions. Some of the cultures from each type of exposure had been pre-treated with Co 235 
ions for 3 days prior to the experiment. Changes in cell number were measured by both NR 236 
and MTT assays. The reduction of MTT is influenced by both reductase enzyme activities 237 
and the supply of NADH/NADPH (the redox status) in the cells and is therefore, a measure 238 
of the metabolic activity and redox status of the cells.  In contrast, the NR assay is not 239 
dependent on these factors. The latter may, however, be altered by changes in the number of 240 
lysosomes in the cells. Resting and activated U937 cell numbers were assessed after 24 and 241 
120h of treatment with the wear debris and/or ions. Figure 2 and Figure 3 summarise the 242 
120h results, there being no significant changes in cell numbers for either resting or activated 243 
U937 cells after 24h of exposure to the different treatments (data not shown).  244 
 245 
After 120h there was a significant decrease in the absorbances measured by NR and MTT 246 
assays respectively in both resting and activated cells, where the metal debris was present. In 247 
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the resting cells, exposure to Co ions for 120h caused an increase in the cell number 248 
compared to controls, which was apparent when measured by both MTT and NR (Figure 2). 249 
Additionally, cells exposed only for 3 days to Co and then the Co ions kept for 120h in 250 
culture medium (PreCo U937+no debris) did not show any differences when compared to 251 
untreated cells. The effect observed on resting cells was not as marked after activation of the 252 
cells by PMA (Figure 3), although increased absorbances in activated cells were detected 253 
where pre-treatment with Co ions had been carried out. When comparing the NR results of 254 
resting cells exposed to the combination of wear debris and Co ions, Co pre-treated cell 255 
numbers were significantly lower than those of non Co pre-treated cells. In fact, all the results 256 
obtained in resting cells were exacerbated to some extent by the pre-treatment with Co ions.  257 
Interestingly, such an effect was not seen after cell activation by PMA. Generally, the 258 
magnitude of responses to both nanoparticles and to Co ions was greater in the resting cells 259 
than in activated cells.  260 
 261 
Viability was assessed by AO/PI double staining. PI is impermeable to intact plasma 262 
membranes, but it easily penetrates the plasma membrane of dead or dying cells and 263 
intercalates with DNA or RNA forming a bright red fluorescent complex. AO is a membrane-264 
permeable, monovalent, cationic dye which binds to nucleic acids in the cells to produce a 265 
fluorescent green product (Bank, 1988). Images 2 and 3 summarise the 120h results, with 266 
there being no significant changes in cell viability for either resting or activated U937 cells 267 
after 24h of exposure to the different treatments (data not shown). After 120h treatment, there 268 
was a decrease in cell number of both resting and activated cells in the presence of debris but 269 
not Co ions. Furthermore, the few cells observed appeared to be mainly apoptotic. 270 
 271 
 272 
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3.3 Cell proliferation 273 
Effects on cell proliferation were assessed with the BrdU cell proliferation assay after 24h of 274 
exposure to the different treatments, at a time when control cells were in the log phase of 275 
growth. The results are summarized in Figure 3. 276 
 277 
Resting cells in the presence of metal debris had a lower rate of proliferation compared with 278 
control cells, although this was not a significant difference. Additionally, the effects on 279 
resting U937 and Co pre-treated resting U937 cells were compared in order to establish if the 280 
pre-treatment with Co influenced the proliferative cell response to the treatments. Co pre-281 
treated resting cells proliferated significantly less than non Co pre-treated resting cells when 282 
exposed to 0.1µM Co alone, suggesting a potential role of Co ions in the inhibition of resting 283 
U937 cell proliferation. The exposure to 0.1µM Co also caused a significant decrease in the 284 
proliferation of activated U937 cells. Moreover, the effects on activated U937 cells and Co 285 
pre-treated activated U937 cells were compared in order to establish if the pre-treatment with 286 
Co influenced the proliferative cell response to the treatments. Co pre-treated activated cells 287 
proliferated significantly more than non Co pre-treated activated cells in the presence of 288 
metal wear debris alone. However, the same effect was observed when cells were exposed to 289 
the combination of metal wear debris and Co ions, showing a significantly higher 290 
proliferation of Co pre-treated activated cells compared to non Co pre-treated activated cells. 291 
No difference was observed in the presence of Co ions alone. These findings differ from the 292 
results of resting cells, which indicates that the cellular activation state may influence the 293 
biological response to metal particles and ions. Although not statistically significant, Co ions 294 
alone increased the rate of proliferation of resting cells, and while at different endpoints, 295 
analogous to the results found with MTT and NR. 296 
 297 
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3.4 Cytokine production measured by  ELISA 298 
Levels of IL-6, TNF-ĮDQG,)1-ȖUHOHDVHGZHUHGHtermined in the culture medium after 120h 299 
of exposure to the different treatments. The results are summarised in Figure 4 and 5.  300 
 301 
Both untreated resting cells and PMA-activated cells (controls on both graphs) secreted the 302 
three cytokines at the 120h culture end point. There was no statistical difference between the 303 
levels of cytokines secreted by treated and untreated resting cells. The Co pre-treatment did 304 
not cause a significant difference to the levels of cytokine secretion by resting U937 cells. 305 
Activated cells exposed to the combination of metal debris and Co ions secreted significantly 306 
more IL-6 and IFN-ȖWKDQFRQWUROFHOOV&RQWUDU\WRWKLVWUHDWPHQWVFDXVHGDGHFUHDVHLQWKH307 
secretion of TNF-ĮE\ DFWLYDWHGFHOOV&RSUH-treated activated cells exposed to 0.1µM Co 308 
secreted significantly less IFN-ȖWKDQQRQ&RSUH-treated cells. 309 
 310 
4. Discussion 311 
MoM hip implants are composed of CoCr alloys, and as such, during wear, both CoCr 312 
nanoparticulate debris and Co and Cr ions are released.  In this study the effects of a high 313 
wear debris concentration and Co ions on U937 cells were studied. After release from MoM 314 
implants, Cr ions tend to bind to the local tissue whereas Co ions tend to remain mobile and 315 
enter the circulation (Simonsen et al., 2012). The Cr forms stable complexes which deposit 316 
DURXQG WKH LPSODQWZKHUHDV&RFRQFHQWUDWLRQV LQSDWLHQWV¶EORRGDUHJHQHUDOO\KLJKHUDQG317 
thus the ions interact with distant tissues and cells to a greater extent.   318 
 319 
The wear debris used in this study was produced from a 39mm ASRTM prosthesis, and 320 
previous work emulating natural gait has shown that approximately 8 mm3 of debris is 321 
produced per million cycles on a simulator from this prosthesis (Leslie et al., 2008). The 322 
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density of the CoCr alloy used was 8.32mg/mm3 (Medley et al., 1996), so 8mm3 of wear 323 
would be equivalent to 66.56mg debris. An active person might walk 3.5 million cycles per 324 
year, so 232.96mg debris/year would be produced locally in the environment of the 325 
prosthesis. The ȝJFP2 metal debris concentration used in this investigation was 326 
chosen to mimic metallosis, a situation where metallic debris infiltrates into the periprosthetic 327 
tissues, with resulting severe adverse effects.  The range of debris and ion concentrations 328 
measured locally varies hugely in the literature, for example, in catastrophic failure of a 329 
prosthesis amounts of wear debris up to 67mg have been reported (Matziolis et al., 2003). 330 
The high metal ion concentrations released from debris in the current experiments simulates 331 
this local situation.  332 
 333 
Exposure to ȝJGHEULVFP2 proved to be toxic for both resting and activated U937 cells 334 
in the presence and absence of Co ions, which could be in part due to the high concentration 335 
of ions released from the particles. However, there was no evidence of toxicity observed after 336 
FHOOH[SRVXUHWRȝ0&RLRQVDORQH,QIDFWWKHFHOOQXPEHUVRIUHVWLQJFXOWXUHVLQFUHDVHG337 
after exposure to the Co ions alone, and this type of response has been reported previously 338 
(Zijlstra et al., 2012), and is thought to represent a protective response to a non-toxic insult.  339 
The statistically significant difference in proliferation between Co pre-treated and non-Co 340 
pre-treated resting cells exposed to 0.1µM Co ions alone, suggests that longer exposure to Co 341 
ions ( >4 days) may result in a toxic response.  These results seem to indicate once more that 342 
Co ions, particularly at high concentrations, are important in the adverse tissue response to 343 
metal wear debris and their effect may differ between cell activation states. 344 
 345 
In the current investigation, a pre-treatment with cobalt ions was carried out to find out if 346 
such tissue pre-exposure and ion dissemination in vivo would have an effect on cell responses 347 
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to subsequent exposure to metal wear debris and ions. Such an effect would be important if a 348 
patient received a second MoM implant or indeed had a revision procedure to replace a 349 
failing implant. Many patients with failing MoM implants have shown high circulating Co 350 
ions in their blood (Antoniou et al., 2008; Tkaczyk et al., 2010b; Bisseling et al., 2011; 351 
Lavigne et al., 2011; Friesenbichler et al., 2012; Penny et al., 2013), and recently the 352 
importance of cobalt release in the inflammatory response to CoCr debris has been 353 
demonstrated (Caicedo et al., 2009; Hart et al., 2012). Results from the present study indicate 354 
that exposure to wear debris had a pronounced detrimental effect on cell number and 355 
metabolic activity of cells pre-treated with Co after an incubation period of 120h. Even 356 
though effects observed in resting cells were exacerbated to some extent by the pre-treatment 357 
with Co ions, such an effect was not seen after cell activation by PMA. PMA exerts its 358 
biologic effects by altering gene expression through the activation of protein kinase C (PKC) 359 
and modulating the activity of transcriptional factors such as nuclear factor kappa-light-360 
chain-enhancer of activated B cells (NFkB) and activator protein 1 (AP1) (Garcia et al., 361 
1999; Daigneault et al., 2010). Thus, it seems unlikely that PKC was directly involved in the 362 
pathways leading to the decrease in cell numbers. Despite the changes in proliferation at 24h 363 
by BrdU assay, no changes in cell number or metabolic activity were observed at this same 364 
endpoint by NR and MTT. Due to the intrinsic characteristics of the assays themselves and 365 
complex dynamics of the balance of cell proliferation and cell death, it is unlikely that the 366 
changes in cell proliferation (cell division) measured at 24h would be simultaneously 367 
apparent as an increase in cell numbers at the same time point. On retrospect, such changes in 368 
terms of cell numbers would have been detectable had we measured this at later time points. 369 
Cells were treated with the Co ion concentration that has been advised by MHRA as the 370 
recommended maximum safe circulating blood level for patients with MoM implants 371 
((MDA/2010/069); http://www.mhra.gov.uk/home/groups/dts-372 
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bs/documents/medicaldevicealert/con093791.pdf). It should be noted that cells pre-treated 373 
with Co ions at a 120h end point would have been exposed to Co for 9 days in total. In 374 
patients, the effects of Co ions and nanoparticles released from metal implants may be 375 
additive in terms of adverse effects.  Contrary to Cr, Co ions tend to remain mobile and as a 376 
result greater Co concentration (compared to Cr) in blood and remote organs have been 377 
reported (Afolaranmi et al., 2012) and will be more likely to affect the responses of distant 378 
organs to metal nanoparticles than the Cr ions. The importance of Co ions in the 379 
inflammatory responses to Co-Cr particles has been recognised, and chronic exposure to 380 
circulating levels of ions, plus high local concentrations may act synergistically in vivo to 381 
trigger and promote implant loosening (Hallab et al., 2001; Caicedo et al., 2010; Hart et al., 382 
2012) . Although circulating systemic Cr levels are generally lower in vivo, it may be 383 
interesting in the future to investigate the influence of prior exposure to Cr ions in the CoCr 384 
wear debris in vitro exposure experiments. The presence of wear debris in the peri-implant 385 
area leads to macrophage phagocytosis of particulate debris and activation, the release of a 386 
variety of mediators, such as free radicals and nitric oxide, and a myriad of proinflammatory 387 
cytokines and chemokines (Sethi et al., 2003). The uptake of the CoCr particles into the cells 388 
was not measured due to technical difficulties in detecting the particles in the cells, but in a 389 
preliminary study phagocytosis by the activated cells was demonstrated using 1µm size 390 
FITC-labelled dextran beads (results not shown).  Differences in the uptake of the CoCr 391 
particles could have occurred in resting and/or activated cells after the different treatments, 392 
and a contribution towards any differences in response cannot be excluded. Generally, the 393 
magnitude of the response to both the particles and the Co ions was greater in the resting cells 394 
than in the activated cells, and so the role of phagocytosis in the toxic responses is not clear.  395 
It has been reported that local acidification may develop during acute and chronic 396 
inflammation (Rajamaki et al., 2013) and high hydrogen ion concentrations down to pH 5.4 397 
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have been found in inflamed tissue (Steen et al., 1995).  In turn, such an acidic environment 398 
created by actively metabolizing immune cells may enhance the corrosion process of the 399 
nanoparticles increasing the amount of metal ions being released (Afolaranmi et al., 2011). 400 
 401 
A number of studies have shown that metal wear particles and high levels of metal ions, 402 
particularly Co and Cr, have a cytotoxic effect on a variety of cells such as human osteoblast-403 
like cell lines (SaOS-2 and MG-63), and human monocytic-like U937 cells in vitro (Allen et 404 
al., 1997; Fleury et al., 2006; Petit et al., 2006). Most of these studies have been focused 405 
mainly on the short-term exposure, acute cell response, or have been limited to evaluation of 406 
one parameter like cell viability or cytokine levels. Studies carried out with U937 cells have 407 
been performed either with resting U937 cells (Ingham et al., 2000; Howling et al., 2003; 408 
Tkaczyk et al., 2010a) or activated U937 cells (Lucarelli et al., 2004; Yagil-Kelmer et al., 409 
2004; Wang et al., 2011), and have investigated the effects of different kinds of metals, 410 
particles, and ions on U937 cells. Papageorgiou et al. (2007) compared the cytotoxic and 411 
genotoxic effects of nanoparticles and micron-sized particles of CoCr alloy using human 412 
fibroblasts in tissue culture. Their results showed that exposure of human fibroblasts to 413 
nanoparticles and micron-sized particles of cobalt chrome alloy, at the same particle mass per 414 
cell, cause different types and amounts of cellular damage. In particular, they found 415 
nanoparticles to be more cytotoxic and induce more DNA damage than micron-sized 416 
particles. This difference in induction of toxicity will contribute to the adverse effects found 417 
in vivo from CoCr nanoparticulate debris generated from MoM implants. Dalal et al. (2012) 418 
compared the responses of human osteoblasts, fibroblasts, and macrophages exposed to 419 
particles of different metal-based particles (i.e., cobalt-chromium (CoCr) alloy, titanium (Ti) 420 
alloy, zirconium (Zr) oxide, and Zr alloy). They found that CoCr-alloy particles were by far 421 
the most toxic and decreased viability and proliferation of human osteoblasts, fibroblasts, and 422 
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macrophages. Germain et al. (2003) studied the effects cobalt±chromium wear particles at 423 
various doses on the viability of U937 cells. CoCr particles at 5µm3 (0.042mg) and 50µm3 424 
(0.42mg) per cell reduced the viability of U937 cells by 42% and 97%, respectively. 425 
Papageorgiou et al. (2007) and Germain et al. (2003) used  high particle concentrations in 426 
comparison to the concentration used in the present study, which indicates that even at lower 427 
doses CoCr nanoparticles can exert cytotoxic effects. (Akbar et al., 2011) investigated effects 428 
of Cr6+ and Co2+ on primary human lymphocytes in vitro. Their results showed that exposure 429 
WRDQGȝ0&U6+ significantly decreased cell viability and increased apoptosis in both 430 
resting and activated lymphocytes. The exposure of resting and activated lymphocytes to 431 
ȝ0 &R2+ also resulted in significant decreases in cell viability accompanied by a 432 
significant increase in apoptosis and they showed that activated cells were significantly more 433 
sensitive to Co2+ toxicity. The concentration of Co ions used in the present study was 1000 434 
fold lower (0.1µM) than that used by Akbar et al. (2011), and no significant effect in cell 435 
viability and proliferation was observed herein. From the literature there is little doubt that 436 
the nanoparticulate debris and metal ions released from MoM implants have toxic effects and 437 
the results in the present study point to the potential for interaction between them in vivo.  438 
 439 
Although not statistically significant, there were higher levels of secretion of IL-6, TNF-Į440 
and IFN-Ȗ E\ UHVWLQJ Fells after 120h of exposure to ȝJFP2 metal debris and the 441 
combination of metal debris and Co ions. In the case of activated cells, there was 442 
significantly higher secretion of IL-6 and IFN-Ȗ E\ FHOOV H[SRVHG WR WKH FRPELQDWLRQ RI443 
ȝJFP2 metal debris and Co ions after 120h. On the other hand, and although not 444 
statistically significant, all treatments caused a reduction in the level of secretion of TNF-Į445 
Contrary to what was observed in resting cells, Co pre-treatment did not seem to cause a 446 
difference in cytokine secretion by activated cells. It should be noted that the secretion of 447 
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cytokines has not been correlated for cell numbers in these experiments, and changes may 448 
reflect cytotoxicity. These results again suggest a larger impact of a chronic exposure and a 449 
key role of Co ions. They also suggest that different molecular pathways are affected in 450 
activated U937 cells when compared to resting U937 cells. 451 
 452 
Bone remodelling involves tight regulation of three proteins, receptor activator of NF-ț% 453 
ligand (RANKL), receptor activator of NF-ț% 5$1.DQGRVWHRSURWHJHULQ 23*7KHVH454 
proteins are key determinants of osteoclastogenesis and regulate bone resorption 455 
(Takayanagi, 2005). Pro-inflammatory cytokines such as IL-6, and TNF-Į FDQ XSUHJXODWH 456 
RANKL expression on osteoblasts and accelerate RANKL signalling, and thus directly 457 
contribute to bone destruction (Oishi et al., 2012). In biomaterials research, TNF-Į,/-1, and 458 
other pro-inflammatory cytokines are also known mediators of the foreign body reaction, an 459 
inflammatory response that can cause both severe tissue damage and premature failure of 460 
implanted materials (Mountziaris and Mikos, 2008). IFN-Ȗ SURPRWHV LQQDWH LPPXQH461 
responses by activating macrophages. In parallel, IFN-ȖH[HUWV UHJXODWRU\IXQFtions to limit 462 
tissue damage associated with inflammation like suppressing osteoclastogenesis (Hu and 463 
Ivashkiv, 2009). Results from this study suggest that high concentrations of metal wear 464 
debris, particularly in the presence of Co ions, promote an immune response with the 465 
secretion of pro-inflammatory cytokines, which can contribute to tissue damage and 466 
ultimately result in aseptic loosening. 467 
 468 
5. Conclusions 469 
The results from this study suggest that a high concentration of metal debris in combination 470 
with Co ions not only have a direct effect on cell viability but also influence cell function. 471 
Previous exposure to Co ions seems to sensitise U937 cells to the toxic effects of both Co 472 
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ions themselves and to nanoparticles, pointing to the potential for interaction in vivo. The 473 
increase in TNF-ĮVHFUHWLRQE\ WKH UHVWLQJ8FHOOVFRXOGEHD IDFWRUFRQWULEXWLQJ WR WKH474 
osteolysis process, while the increase in IFN-ȖSURGXFWLRQE\ WKHDFWLYDWHGFHOOVFRXOGEHD475 
cellular effort to counteract tissue damage. This also suggests that cellular activation state 476 
affects the biological response to wear debris and for this reason caution should be taken 477 
when choosing in vitro models to study immune and molecular responses.  Moreover, these 478 
findings mean that the survival and well-functioning of a second implanted MoM device 479 
could be compromised in patients undergoing revision surgery or receiving a second device, 480 
due to the interactions between recirculating Co ions and CoCr nanoparticles. 481 
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 Figure Captions (all figures are 2-column fitting images) 693 
Image 1. Scanning Electron Microscopy image of simulator generated wear debris from an 694 
ASRTM hip implant. Image taken at 15kX with a FE-SEM Hitachi SU-6600. 695 
Image 2. Fluorescence microscopy images (40X) following PI (Dead cells, red)/AO (Live 696 
cells, green) staining of resting U937 and Co pre-treated resting U937 cells exposed to 697 
ȝJGHEULVFP2 (5mg debris/1x106 cells) , 0.1µM Co and ȝJGHEULVFP2 (5mg 698 
25 
 
debris/1x106 cells) + 0.1µM Co for 120h. Images are representative of 5 independent images 699 
IURPHDFKVDPSOHDWHDFKHQGSRLQW³%´LQGLFDWHVFHOOEOHEELQJ³6´LQGLFDWHVFHOOVKULQNDJH700 
DQG³1´LQGLFDWHVQHFURVLVFRORXUUHSURGXFWLRQonly on the web). 701 
 702 
Image 3. Fluorescence microscopy images (40X) following PI (Dead cells, red)/AO (Live 703 
cells, green) staining of activated U937 and Co pre-treated resting U937 cells exposed to 704 
ȝJGHEULVFP2 (5mg debris/1x106 cells) , 0.1µM Co and ȝJGHEULVFP2 (5mg 705 
debris/1x106 cells) + 0.1µM Co for 120h. Images are representative of 5 independent images 706 
IURPHDFKVDPSOHDWHDFKHQGSRLQW³%´LQGLFDWHVFHOOEOHEELQJDQG³6´LQGLFDWHVFHOO707 
shrinkage (colour reproduction only on the web). 708 
 709 
Figure 1. Neutral Red and MTT assays measured in resting cells at 120h. Results are 710 
percentage values (Mean ± SEM, n=9) where 100% corresponds to control values (dash 711 
lines). PreCo-debris: cells pre-treated with Co ions and then the Co ions kept in culture 712 
medium throughout the experiment. *Significantly different from control values (p<0.05) by 713 
one-ZD\$129$IROORZHGE\'XQQHWW¶VPXOWLSOH FRPSDULVRQ WHVW 6LJQLILFDQWO\GLIIHUHQW714 
from non Co pre-treated cell values (p<0.05) by 2 sample t-Test.  715 
 716 
Figure 2. Neutral Red and MTT assays measured in activated cells at 120h. Results are 717 
percentage values (Mean ± SEM, n=9) where 100% corresponds to control value (dash lines). 718 
PreCo+debris: cells pre-treated with Co ions and then exposed to treatments. PreCo-debris: 719 
cells pre-treated with Co ions and then the Co ions kept in culture medium throughout the 720 
experiment. *Significantly different from control values (p<0.05) by one-way ANOVA 721 
IROORZHG E\ 'XQQHWW¶V PXOWLSOH FRPSDULVRQ WHVW 6LJQLILFDQWO\ GLIIHUHQW IURP QRQ &R SUH-722 
treated cell values (p<0.05) by 2 sample t-Test. 723 
26 
 
 724 
Figure 3. Cell proliferation at 24h measured by BrdU. Results are percentage values 725 
(Mean±SEM, n=8) where 100% corresponds to control untreated cells (dash lines). PreCo: 726 
cells pre-treated with Co ions. *Significantly different from control values (p<0.05) by one-727 
ZD\$129$IROORZHGE\'XQQHWW¶VPXOWLSOHFRPSDULVRQWHVWSignificantly different from 728 
non Co pre-treated cell values (p<0.05) by 2 sample t-Test. 729 
 730 
Figure 4. Resting U937 cell cytokine secretion measured by ELISA after 120h of 731 
treatment. Results are expressed as cytokine concentration values per 1000 cells (± SEM, 732 
n=4). Untreated resting U937 cells were used as control. *Significantly different from control 733 
values (p<0.05) by one-ZD\$129$IROORZHGE\'XQQHWW¶V multiple comparison test. 734 
Significantly different from non Co pre-treated resting cell values (p<0.05) by 2 sample t-735 
Test.  736 
 737 
Figure 5. Activated U937 cell cytokine secretion measured by ELISA after 120h of 738 
treatment. Results are expressed as cytokine concentration values per 1000 cells (± SEM, 739 
n=5). Untreated activated U937 cells were used as control. *Significantly different from 740 
control values (p<0.05) by one-ZD\$129$IROORZHGE\'XQQHWW¶VPXOWLSOHFRPSDULVRQ741 
test. Significantly different from non Co pre-treated activated cell values (p<0.05) by 2 742 
sample t-Test. 743 
  744 
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Table 1. Release of Co and Cr ions into culture medium from metal wear debris in vitro. 
Incubation Cr  release 
 (ng/ml) 
Co  release  
(ng/ml) 
Mo release 
 (ng/ml) 
RPMI control 0.19 +/-0.06 0.09 +/- 0.09 6.32 +/- 0.16 
RPMI plus CoCr 
wear debris 
18.18 +/- 2.64 1259.41 +/- 39.58 124.60 +/- 2.70 
 
5mg wear debris were incubated for 24h at 37 oC in 1ml complete RPMI-1640 medium in the 
presence of 10% foetal bovine serum.  Metal ion release was measured by ICPMS Results are 
expressed as mean +/- SEM (n=3).  Release of each ion (ng/ml) from wear debris was 
significantly different from the concentration in control RPMI medium by one-way ANOVA 
IROORZHGE\'XQQHWW¶VPXOWLSOHFRPSDULVRQWHVW37KHGLVVROXWLRQUDWHRIWKH&R&U
wear debris in terms of Co release was 0.000042% over the 24h period. 
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Highlights 745 
x Metal debris in combination with Co ions influence cell function 746 
x Pre-exposure to Co ions seems to sensitise cells to the toxic effects particles 747 
x Experimental conditions may not allow to discriminate between cytotoxic and cytostatic 748 
x Cellular activation state affects the biological response to wear debris 749 
x Interaction between circulating ions and particles may threaten MoM device survival 750 
 751 
 
